Stuart Therapeutics Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 6

Stuart Therapeutics General Information

Description

Developer of a synthesized peptide therapeutic platform intended to repair disease-damaged helical collagen in the eye. The company's method of action results in accelerated healing of epithelial cells, restoration of nerve function, and reduction of inflammation in various ophthalmic diseases and offers a way to address indications such as dry eye disease, dry age-related macular degeneration, and glaucoma, enabling physicians to repair the damaged collagen and reduction of inflammation.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 411 Southeast Osceola Street
  • Suite 203
  • Stuart, FL 34994
  • United States
+1 (772)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 411 Southeast Osceola Street
  • Suite 203
  • Stuart, FL 34994
  • United States
+1 (772)

Stuart Therapeutics Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Stuart Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator Completed Clinical Trials - Phase 3
2. Early Stage VC 09-Mar-2022 Completed Clinical Trials - Phase 3
1. Early Stage VC (Series A) 23-Mar-2021 $11M $11M Completed Clinical Trials - Phase 3
To view Stuart Therapeutics’s complete valuation and funding history, request access »

Stuart Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Stuart Therapeutics’s complete cap table history, request access »

Stuart Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a synthesized peptide therapeutic platform intended to repair disease-damaged helical collagen in the eye.
Drug Discovery
Stuart, FL
5 As of 2021

Tel Aviv, Israel
 

Rockville, MD
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Stuart Therapeutics Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Azura Ophthalmics Venture Capital-Backed Tel Aviv, Israel
Regenerx Formerly VC-backed Rockville, MD
Oyster Point Corporate Backed or Acquired Princeton, NJ
Aldeyra Therapeutics Formerly VC-backed Lexington, MA
To view Stuart Therapeutics’s complete competitors history, request access »

Stuart Therapeutics Executive Team (10)

Name Title Board Seat
Eric Schlumpf Co-Founder, Chief Executive Officer, President & Board Member
Don Stires Chief Financial Officer
Diane Black Chairman, Audit Committee & Board Member
Robert Baratta MD Executive Chairman and Board Member
Shawn DeLorey Co-Founder, Executive Vice President of Program Management and Corporate Development
You’re viewing 5 of 10 executive team members. Get the full list »

Stuart Therapeutics Board Members (5)

Name Representing Role Since
Charles Wykoff Ph.D Self Advisory Board
Diane Black Stuart Therapeutics Chairman, Audit Committee & Board Member
Eric Schlumpf Stuart Therapeutics Co-Founder, Chief Executive Officer, President & Board Member
Jodi Luchs MD Stuart Therapeutics Chief Medical Officer, Chairman of the Nominating Committee & Board Member
Walter Flamenbaum MD Self Chairman of Compensation Comittee, Board Member & Strategic Advisor
To view Stuart Therapeutics’s complete board members history, request access »

Stuart Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Stuart Therapeutics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Biobrit Venture Capital Minority
InFocus Capital Partners Venture Capital Minority
Keiretsu Forum Venture Capital Minority
MiMo Capital (Miami) Venture Capital Minority
WARF Ventures Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Stuart Therapeutics FAQs

  • When was Stuart Therapeutics founded?

    Stuart Therapeutics was founded in 2018.

  • Who is the founder of Stuart Therapeutics?

    Eric Schlumpf and Shawn DeLorey are the founders of Stuart Therapeutics.

  • Who is the CEO of Stuart Therapeutics?

    Eric Schlumpf is the CEO of Stuart Therapeutics.

  • Where is Stuart Therapeutics headquartered?

    Stuart Therapeutics is headquartered in Stuart, FL.

  • What is the size of Stuart Therapeutics?

    Stuart Therapeutics has 5 total employees.

  • What industry is Stuart Therapeutics in?

    Stuart Therapeutics’s primary industry is Drug Discovery.

  • Is Stuart Therapeutics a private or public company?

    Stuart Therapeutics is a Private company.

  • What is Stuart Therapeutics’s current revenue?

    The current revenue for Stuart Therapeutics is .

  • How much funding has Stuart Therapeutics raised over time?

    Stuart Therapeutics has raised $11M.

  • Who are Stuart Therapeutics’s investors?

    Biobrit, InFocus Capital Partners, Keiretsu Forum, MiMo Capital (Miami), and WARF Ventures are 5 of 6 investors who have invested in Stuart Therapeutics.

  • Who are Stuart Therapeutics’s competitors?

    Azura Ophthalmics, Regenerx, Oyster Point, and Aldeyra Therapeutics are competitors of Stuart Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »